Inositol vs Magnesium
Both are commonly discussed for anxiety & stress and mood. Magnesium has the stronger research base (moderate evidence), while Inositol is rated weak.
Evidence last reviewed May 2026
Evidence
🟠Weak Evidence
🟡Moderate Evidence
Research says
Research agrees
Research agrees
Expert mentions
96
1 recommend
315
4 recommend
Studies
20
referenced
20
referenced
Study dose
2000–18000mg
Doses in PCOS and gestational diabetes research typically range from 2,000–4,000 mg/day of myo-inositol, while psychiatric studies (OCD, panic disorder, bipolar) have used up to 18,000 mg/day in divided doses; the D-chiro-inositol form is studied at much lower doses and the optimal myo- to D-chiro ratio (e.g., 40:1) varies by indication.
200–400mg
Studies and expert sources consistently reference 200–400 mg of elemental magnesium daily; the required capsule dose varies significantly by form, as elemental magnesium content differs — for example, magnesium glycinate is roughly 14% elemental magnesium, meaning a 400 mg capsule delivers only ~56 mg elemental magnesium.
Best timing
MorningEveningWith food
EveningWith food
Who recommends
Caution
Generally safe
Generally safe
Inositol
Key findings
- ·Multiple meta-analyses support myo-inositol (typically 2–4 g/day) for improving metabolic and hormonal parameters in women with PCOS, representing the strongest evidence base for this supplement.
- ·Two meta-analyses of randomized controlled trials indicate that myo-inositol supplementation during pregnancy may reduce the incidence of gestational diabetes mellitus.
- ·Systematic reviews and network meta-analyses suggest inositol may provide modest benefit in Hashimoto's thyroiditis and subclinical hypothyroidism, though evidence is less definitive.
Evidence gaps
- ·Long-term safety and efficacy data are lacking across most indications — most trials are short-duration and do not establish whether benefits persist or whether adverse effects emerge with extended use.
- ·The optimal dose, form (myo-inositol vs. D-chiro-inositol vs. combined), and ratio for specific conditions have not been established through rigorous head-to-head dose-comparison trials.
Magnesium
Key findings
- ·A strong-quality meta-analysis found oral magnesium supplementation improved sleep outcomes in older adults with insomnia, partially supporting claims about magnesium's role in sleep quality and onset.
- ·A strong-quality meta-analysis found magnesium supplementation positively affected glucose metabolism parameters in people with or at risk of type 2 diabetes, suggesting metabolic benefits in at-risk populations.
- ·Moderate-quality reviews support a role for magnesium in migraine prevention and in cardiovascular and cardiometabolic health, though causality and effect sizes require further confirmation.
Evidence gaps
- ·Most evidence comes from older adults or clinically deficient populations; it remains unclear whether magnesium supplementation benefits healthy individuals with adequate baseline magnesium levels.
- ·Form-specific clinical outcome data (e.g., glycinate, threonate, malate) is largely absent from high-quality trials, making it impossible to definitively recommend one form over another for specific outcomes like sleep or cognition.